Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) Trial.

Amol A SuraYuwei SunAmit K ReddyS R RathinamJohn A GonzalesRadhika ThundikandyRajesh VedhanayakiAnuradha KanakathBala MuruganThuy A DoanLyndell L LimEric B SuhlerHassan A Al-DhibiNisha R Acharyanull null

Published in: Ocular immunology and inflammation (2023)

Dose reduction of antimetabolites was not associated with worse outcomes in this subanalysis of a uveitis trial.

Keyphrases

juvenile idiopathic arthritis
phase iii
study protocol
ankylosing spondylitis
phase ii
clinical trial
high dose
open label
rheumatoid arthritis
robot assisted
low dose
mesenchymal stem cells
systemic lupus erythematosus
insulin resistance
double blind